Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma? Read more about Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?
An orientation to the US National Cancer plan for the research community. Read more about An orientation to the US National Cancer plan for the research community.
Predicting five-year interval second breast cancer risk in women with prior breast cancer. Read more about Predicting five-year interval second breast cancer risk in women with prior breast cancer.
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355. Read more about Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.
Response to Omoleye, Esserman, Olufunmilayo. Read more about Response to Omoleye, Esserman, Olufunmilayo.
A roadmap to establishing global oncology as a priority initiative within a National Cancer Institute-designated cancer center. Read more about A roadmap to establishing global oncology as a priority initiative within a National Cancer Institute-designated cancer center.
Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density. Read more about Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
Can early prostate cancer screening help address mortality disparities among Black men? Read more about Can early prostate cancer screening help address mortality disparities among Black men?
Severe anal intraepithelial neoplasia trends and subsequent invasive anal cancer in the United States. Read more about Severe anal intraepithelial neoplasia trends and subsequent invasive anal cancer in the United States.
The National Cancer Institute's Cancer Disparities Research Partnership Program: a unique funding model 20 years later. Read more about The National Cancer Institute's Cancer Disparities Research Partnership Program: a unique funding model 20 years later.
